Thanks to significant local and global efforts, great progress has been made in reducing the burden of malaria in the last 20 years. But more work remains to ensure people are able to live healthy and productive lives, free from the threat of this deadly disease. Malaria still takes the lives of 400,000 people each year, most of them children under five. And it robs the African continent of billions of dollars in lost productivity annually. As a major employer and investor in many malaria-endemic countries, ExxonMobil has witnessed the devastation of malaria firsthand. We’ve seen its impact on the lives of employees, their families and their communities. That’s why we are part of an international effort to prevent, treat and cure this deadly disease.
ExxonMobil has partnered with the world’s leading organizations that work on the front-lines in the fight against malaria. Together, we are collaborating on four fronts.
We invest to build capacity and support education about malaria.
Using vital information about prevention and treatment to help build capacity among health workers and inform policies to protect vulnerable communities.
We improve access to tools for prevention, diagnosis and elimination.
Providing families with the tools to prevent, diagnose and treat malaria, including insecticide-treated bed nets, intermittent preventative treatment for pregnant women, rapid diagnostic tests and antimalarial drugs.
We use our resources and expertise to advance research and development
Supporting the work of researchers who are addressing antimalarial resistance and developing new drugs and vaccines.
We support the next-generation global health leaders.
Fostering the next generation of young leaders to take on malaria and other diseases through scholarships and training opportunities.